Diuretic effect. Other diuretics
Conditions
Interventions
Intervention 1: Intervention group: Oral yellow herbal Dandelion Capsule 300 mg with production license by the Nik Daroie Shafasaz Amiran Company and produced in Booali Daro Pharmaceutical Factory of
Sponsors
Ghoum University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Healthy people in the age range of 18-65 years (by referring to the health center) who have a GFR above 60% by creatinine test.
Exclusion criteria
Exclusion criteria: History of allergy to plants of asteraceae. People with bile duct or intestinal obstruction People with acute cholecystitis, empyema, acute gall bladder inflammation People who have digestive diseases, gastritis, irritable bowel syndrome People with diabetes and kidney failure Pregnant and lactating women and Married women who are in childbearing age and do not use reliable contraception method Weight below 50 kg Patients with uncontrolled underlying diseases such as hypertension and... Patients who take medications that interfere with dandelion herbal capsules. Medicines such as: lithium, digoxin, corticosteroids such as prednisone, niacin/nicotinic acid, metronidazole, disulfiram, tetracycline and fluoroquinolone antibiotics (such as ciprofloxacin), hypoglycemic drugs, antiplatelet drugs, diuretics, antacids such as Famotidine and omeprazole People who take the following herbs: bloodroot, cat's paw, chamomile, chaparral, fennel, samiana, Echinacea angustifolia, gorse, grapefruit juice, licorice, oregano, red clover, St. John's wort, wild cherry, and yucca. Alcohol consumption history (more than 10 grams per day for women and more than 20 grams per day for men)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urine volume. Timepoint: The first day of the study (negative 2), the second day of the study (negative 1), the third day of the study (intervention day=day zero), the fourth day (tomorrow of the intervention day=day 1). Method of measurement: Collect in the included containers.;Urinary frequency. Timepoint: The first day of the study (negative 2), the second day of the study (negative 1), the third day of the study (intervention day=day zero), the fourth day (tomorrow of the intervention day=day 1). Method of measurement: counting.;Amount of fluids consumed. Timepoint: The first day of the study (negative 2), the second day of the study (negative 1), the third day of the study (intervention day=day zero), the fourth day (tomorrow of the intervention day=day 1). Method of measurement: Record. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contacthoda Abolhasani
Ghoum University of Medical Sciences
Outcome results
None listed